Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2015 May;29(4):219-20.
doi: 10.1155/2015/943410.

Noninvasive diagnosis of liver fibrosis: The importance of being reimbursed

Comment

Noninvasive diagnosis of liver fibrosis: The importance of being reimbursed

Giada Sebastiani et al. Can J Gastroenterol Hepatol. 2015 May.
No abstract available

PubMed Disclaimer

Figures

Figure 1)
Figure 1)
Number of Fibroscan (Echosens, France) examinations performed at McGill University Health Centre (Montreal, Quebec) from 2009 to 2014. Arrow indicates the year when reimbursement for the procedure was implemented

Comment in

  • The Authors respond.
    Yoshida EM, Kan VY, Ford JA, Marquez Azalgara V. Yoshida EM, et al. Can J Gastroenterol Hepatol. 2015 May;29(4):222. doi: 10.1155/2015/521479. Can J Gastroenterol Hepatol. 2015. PMID: 25965446 Free PMC article. No abstract available.

Comment on

References

    1. Kan VY, Azalgara VM, Ford JAE, Kwan PWC, Erb SR, Yoshida EM. Patient preference and willingness to pay for transient elastography versus liver biopsy: A perspective from British Columbia. Can J Gastroenterol Hepatol. 2015;29:72–6. - PMC - PubMed
    1. Sebastiani G, Ghali P, Wong P, Klein MB, Deschenes M, Myers RP. Physicians’ practices for diagnosing liver fibrosis in chronic liver diseases: A nationwide, Canadian survey. Can J Gastroenterol Hepatol. 2014;28:23–30. - PMC - PubMed
    1. Castera L, Denis J, Babany G, Roudot-Thoraval F. Evolving practices of non-invasive markers of liver fibrosis in patients with chronic hepatitis C in France: Time for new guidelines? J Hepatol. 2007;46:528–529. author reply 529–30. - PubMed
    1. Myers RP, Fong A, Shaheen AA. Utilization rates, complications and costs of percutaneous liver biopsy: A population-based study including 4275 biopsies. Liver Int. 2008;28:705–12. - PubMed
    1. Mehta SH, Lau B, Afdhal NH, Thomas DL. Exceeding the limits of liver histology markers. J Hepatol. 2009;50:36–41. - PMC - PubMed